The Latest in Hematology and Oncology

Oncology Practice

ASCO issues guideline on communication with patients

September 11, 2017

Oncology Practice

Checkmate 238: Nivolumab bests ipilimumab for resectable stage III or IV melanoma

September 11, 2017

Oncology Practice

Diagnosing high-risk keratinocyte carcinomas in the dermatology clinic

September 11, 2017

Nonmelanoma Skin Cancer

Oncology Practice

Osimertinib bests PFS achieved with standard care for EGFR-mutated NSCLC

September 11, 2017

Lung Cancer

Hematology Times

Study: Many cancer patients don’t understand clinical trials

September 11, 2017

Oncology Practice

PACIFIC: Durvalumab extends PFS in stage 3 NSCLC

September 10, 2017

Hematology News

Plerixafor doesn’t overcome HPC failure in R-hyperCVAD for mantle cell lymphoma

September 10, 2017

Hematology Times

Team identifies mutation that causes EPP

September 10, 2017

Anemia

Oncology Practice

Minimally invasive esophagectomy may mean less major morbidity

September 9, 2017

Hematology News

CB-5083 showed significant activity against B-ALL

September 9, 2017

Hematology Times

CCSs have higher burden of chronic conditions

September 9, 2017

Hematology News

Absorb bioresorbable scaffold folds

September 8, 2017

Thrombosis

Hematology News

New AML approvals changing the treatment landscape

September 8, 2017

The Journal of Community and Supportive Oncology

Bone remodeling associated with CTLA-4 inhibition: an unreported side effect

September 8, 2017

The Journal of Community and Supportive Oncology

Management of polycythemia vera in the community oncology setting

September 8, 2017

Patient & Survivor Care